Gonadorelin vs Kisspeptin
The table compares the compounds’ key data from their entry pages. Open each compound’s full entry for details. Educational content, not medical advice.
Gonadorelin (GnRH) | Kisspeptin-10 | |
|---|---|---|
| What it is | Synthetic GnRH hormone that starts the production of sex hormones; an approved medicine in Europe, banned in sport. | Experimental peptide that stimulates sex hormone production in the brain; being studied, but its medical benefit is not proven. |
| Type | GnRH (decapeptide) | Hypothalamic neuropeptide |
| Structure | pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH₂ | Chain of ten amino acids (YNWNSFGLRF) |
| Status | EU registered | Phase 2 |
| Route | SC, IV | SC, IV |
| Storage | 2–8°C | 2–8°C |
| Full entry | Open → | Open → |
Gonadorelin or kisspeptin: what is the difference?
Both are involved in starting the production of sex hormones, but they act at different places. Kisspeptin is a peptide made in the hypothalamus, the hormone centre of the brain, and it stimulates the nerve cells that start the production of sex hormones; gonadorelin is a synthetic copy of GnRH, a hormone made in the brain, and it stimulates the pituitary gland. The gonadorelin entry also describes that the signal has to be rhythmic: when the signal is continuous, the target cells become insensitive and the production of sex hormones stops. Their status differs: gonadorelin is an approved medicine in Europe, used for fertility testing and to treat patients with hormone deficiency, while kisspeptin is an experimental compound in the second phase of clinical trials, and its medical benefit is not proven.

